| 08:30 |
Coffee |
|
| 09:00 |
Welcome and introduction |
Kimmo Porkka
Professor, Helsinki University Hospital Comprehensive Cancer Center, Department of Hematology |
| |
Session I: Updates in hematology (chair: K. Porkka) |
|
| 09:00 |
Genome-driven therapy of ALL |
Charles Mullighan
Professor, Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN |
| 09:40 |
Clinical implications of clonal hematopoiesis
|
Lambert Busque
Professor of Medicine, Université de Montréal, and Chief of Molecular Diagnostic and Coordinator of the Cancer Program, Hôpital Maisonneuve-Rosemont, Montréal, Québec
|
| 10:20 |
Coffee, exhibitions |
|
| 10:40 |
Targeted therapy of AML |
Jorge Cortes
Professor, Department of Leukemia, MD Anderson Cancer Center, Houston, TX
|
| 11:20 |
Clinical trials of hematology: are we testing trivialities?
|
Vinay Prasad
Assistant Professor of Medicine, Division of Hematology Oncology in the Knight Cancer Institute, OHSU, Portland, OR
|
| 12:00 |
Lunch |
|
| |
|
|
| |
Session II: Updates in stem cell transplantation
|
| 13:00 |
Welcome
|
Riitta Niittyvuopio
Head of the transplantation unit, Helsinki University Hospital Comprehensive Cancer Center, Department of Hematology
|
| 13:00 |
DLI and pharmacologic interventions post allo-HSCT |
Jürgen Kuball
Professor, Department of Hematology, Utrecht Cancer Center |
| 13:50 |
Terveisiä Veripalvelusta |
Tiina Linjama
Erikoislääkäri, SPR Veripalvelu, Helsinki
|
| 14:20 |
Allogeenisen kantasolusiirtopotilaan gynekologinen hoito ja seuranta |
Elina Holopainen
LT, Naistentautien ja synnytysten erikoislääkäri, HUS |
